Filing Details
- Accession Number:
- 0001649094-24-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-25 16:43:52
- Reporting Period:
- 2024-06-24
- Accepted Time:
- 2024-06-25 16:43:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1258693 | Grant Pickering | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-24 | 15,000 | $2.03 | 493,888 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-24 | 10,341 | $75.39 | 483,547 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-24 | 4,471 | $76.17 | 479,076 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-24 | 188 | $76.80 | 478,888 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2024-06-24 | 15,000 | $0.00 | 15,000 | $2.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 197,327 | 2028-07-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 144,746 | Indirect | By Children's Trust |
| Common Stock | 144,746 | Indirect | By Children's Trust |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $74.735 to $75.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $75.74 to $76.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $76.74 to $76.81. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares are held directly by a trust for the benefit of the Reporting Person's son.
- Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
- Stock Option is fully vested and exercisable.
Billionaire Hedge Funds
